Fig. 2From: An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism a Mean (±SD) sperm concentration (×106) from Day 1 to Week 52 of the combined treatment phase; b Total sperm count (×106/ejaculate) during the combined treatment phaseBack to article page